ABCL (STOCKS)
AbCellera Biologics Inc. Common Shares
$5.200000
-0.040000 (-0.76%)
Prev close: $5.240000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Carl Lars G. Hansen
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,604.75M
- Employees
- 596
- P/E (TTM)
- -10.93
- P/B (TTM)
- 1.70
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
10
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.14 | $-0.20 | +0.0596 | +29.86% |
|
Dec 2025 (Q4)
|
$-0.03 | $-0.18 | +0.1475 | +83.10% |
|
Sep 2025 (Q3)
|
$-0.19 | $-0.17 | -0.0179 | -10.40% |
|
Jun 2025 (Q2)
|
$-0.12 | $-0.17 | +0.0493 | +29.12% |
Financial Statements
| Revenues | $79.21M |
| Benefits Costs and Expenses | $253.36M |
| Costs And Expenses | $253.36M |
| Nonoperating Income/Loss | $37.82M |
| Operating Expenses | $291.17M |
| Research and Development | $191.00M |
| Other Operating Expenses | $93.17M |
| Operating Income/Loss | -$211.96M |
| Income/Loss From Continuing Operations After Tax | -$143.96M |
| Income/Loss From Continuing Operations Before Tax | -$174.15M |
| Income Tax Expense/Benefit | -$30.19M |
| Net Income/Loss | -$143.96M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$143.96M |
| Net Income/Loss Available To Common Stockholders, Basic | -$143.96M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.48 |
| Diluted Earnings Per Share | -$0.48 |
| Basic Average Shares | 900,799,293 |
| Diluted Average Shares | 900,799,293 |
| Assets | $1.31B |
| Current Assets | $664.60M |
| Cash | $504.73M |
| Accounts Receivable | $39.16M |
| Inventory | $7.86M |
| Other Current Assets | $112.84M |
| Noncurrent Assets | $642.52M |
| Intangible Assets | $37.46M |
| Other Non-current Assets | $605.06M |
| Liabilities | $369.03M |
| Current Liabilities | $47.29M |
| Wages | $3.93M |
| Other Current Liabilities | $43.37M |
| Noncurrent Liabilities | $321.74M |
| Equity | $938.08M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $938.08M |
| Liabilities And Equity | $1.31B |
| Net Cash Flow From Operating Activities | -$153.26M |
| Net Cash Flow From Operating Activities, Continuing | -$153.26M |
| Net Cash Flow From Investing Activities | $54.73M |
| Net Cash Flow From Investing Activities, Continuing | $54.73M |
| Net Cash Flow From Financing Activities | $15.30M |
| Net Cash Flow From Financing Activities, Continuing | $15.30M |
| Exchange Gains/Losses | $469.00K |
| Net Cash Flow | -$82.76M |
| Net Cash Flow, Continuing | -$83.23M |
| Comprehensive Income/Loss | -$143.72M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$139.38M |
| Other Comprehensive Income/Loss | -$56.88M |